Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapy.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 18207598.
- Also identified by DOI 10.1016/j.radonc.2007.12.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated the impact of low dose daily cisplatin on distant metastasis-free survival (DMFS) in locally advanced head and neck cancer treated with hyperfractionated radiotherapy (77Gy in 70 fractions in 35 treatment days). In locally controlled tumors cisplatin led to better DMFS (p=0.0272); Cisplatin may have acted independently of micrometastasis in locally advanced H&N cancer.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Squamous Cell
- Cisplatin
- Head and Neck Neoplasms